Biological Age Platform
We are building one of MENA's largest healthy-ageing datasets on top of the Longevium clinical network: labs, ultrasound, body composition, wearables. The goal — a regional reference model of biological age.


Dubai has decided to age slower — as national strategy. Longevium Health is the science bet behind that decision: a longevity R&D program in Dubai, built on the Longevium clinical network and a planned AI Research Center. Five directions, one roadmap.
Western medicine waits for something to break and then bills for the repair. Longevium Health is built on a different bet: biological age is a number you can move, and ageing is an engineering problem. Dubai has already made that bet national strategy — our job is to turn it into a concrete R&D agenda.
The core is regenerative medicine and preventive diagnostics: peptide protocols, exosomes, evidence-based methods of slowing ageing. We are building our own pipeline of peptide protocols and evaluating a compounding pharmacy model as a way to bring them to the clinic faster than the market. AI is used to prioritize molecules and biomarkers before synthesis.
Early diagnostics is the core of preventive longevity medicine: catch the problem before it becomes disease. Everything we develop is measured on our own patients first, and only then moves further.
We are building one of MENA's largest healthy-ageing datasets on top of the Longevium clinical network: labs, ultrasound, body composition, wearables. The goal — a regional reference model of biological age.

A patient model in development that aims to predict heart attack, diabetes, oncology and dementia and let clinicians simulate protocols before applying them. A bet on the technology many call the foundation of precision medicine.

An R&D program on algorithms across blood tests, genetics, CT, MRI and ultrasound. The ambition — validated models and a licensable platform for third-party clinics, with our own IP.

We are establishing a clinical research center in Dubai to run pilots of new diagnostics, AI solutions and longevity protocols with partners. UAE regulatory speed is part of the thesis.

A direction we are entering: swallowable capsules for GI examination without gastroscopy, and automated skin scanners for early melanoma detection. Partnerships and pilots — open.

A doctor's AI assistant right in the browser. Reads the chart while the physician writes — on top of any EMR, no integrations. Cross-checks WHO, NICE, ESC, IDSA and ADA guidelines in real time.
Catches gaps, missed prescriptions, wrong antibiotics and forgotten follow-ups. Shows a live score across five clinical axes.
The patient uploads a unified health profile, computes biological age, plans visits and receives personal protocols.
One layer holds all data and the patient's protocol. Subscription revenue; research, doctors and clinic locking into one AI ecosystem — the first honest step toward a patient digital twin.
PhD, preventive medicine physician and vascular specialist with 14 years of clinical experience. Founder and CEO of Longevium — a longevity clinic ecosystem in Dubai: 3 clinics, 30,000+ patients, 10,000+ trained physicians.
Bridges clinical practice and strategy: develops proprietary protocols in metabolic health, hormones, GLP-1, peptide and regenerative medicine. Sets the scientific agenda of Longevium Health and the Longevium AI Research Center.
"Health is not reactive care. It is engineered longevity."
How Dubai is becoming the hub of the next healthcare wave — featuring Longevium and its approach to extending healthspan.
A review of Dubai's longevity market and Longevium's stance: evidence-based medicine over anti-ageing marketing.
Longevium physicians comment on the proper use of tumour markers within early cancer detection programs.
Longevium is recognized as a Longevity Spot by Longevity Germany — an independent European registry of evidence-based longevity clinics.
While Western regulators hold hearings, MENA holds appointments. Longevium Health builds on the Longevium clinical network in Dubai and its own R&D agenda. If you're developing a technology, device, biomarker or AI solution in longevity — we bring the clinical venue, patients and partner infrastructure to validate it here and reach MENA ahead of your competitors.